Galmed Pharmaceuticals

(NASDAQ) GLMD

Current Price$0.58

Market Cap$4.04M

Since IPO (2014)-100%

5 Year-100%

1 Year-62%

1 Month+3%

Galmed Pharmaceuticals Financials at a Glance

Market Cap

$4.04M

Revenue (TTM)

$0.00

Net Income (TTM)

-$10.31M

EPS (TTM)

-$2.33

P/E Ratio

-0.26

Dividend

$0.00

Beta (Volatility)

0.98 (Low)

Dividend

$0.00

Beta (Volatility)

0.98 (Low)

Price

$0.58

Volume

7,504

Open

$0.59

Price

$0.58

Volume

7,504

Open

$0.59

Previous Close

$0.61

Daily Range

$0.58 - $0.63

52-Week Range

$0.41 - $2.34

Estimated Earnings Date

Jul 30, 2026

Dividend

$0.00

Beta (Volatility)

0.98 (Low)

Price

$0.58

Volume

7,504

Open

$0.59

Previous Close

$0.61

Daily Range

$0.58 - $0.63

52-Week Range

$0.41 - $2.34

Estimated Earnings Date

Jul 30, 2026

GLMD News

These Small Cap Biopharma Stocks Lost as Much as 34.1% in October. Are They Buys?

Maxx ChatskoNov 8, 2018

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Galmed Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Allen J. Baharaff

Website

galmedpharma.com

Headquarters

Ramat Gan, 6578317, IL

GLMD Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-64%

Return on Capital

-54%

Return on Assets

-55%

Earnings Yield

-3.85%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.04M

Shares Outstanding

6.60M

Volume

7.50K

Avg. Volume

3.34M

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$8.51M

EBITDA

-$10.31M

Operating Cash Flow

-$6.32M

Capital Expenditure

$0.00

Free Cash Flow

-$6.32M

Cash & ST Invst.

$18.16M

Total Debt

$0.00

Galmed Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$4.04M

N/A

Market Cap/Employee

$1.35M

N/A

Employees

N/A

Net Income

-$4.82M

-50.1%

EBITDA

-$4.82M

-74.5%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Total Cash

$18.16M

+18.4%

Total Debt

$0.00

N/A

Accounts Receivable

$80.00K

-61.7%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-55.34%

N/A

Return on Invested Capital

-53.92%

N/A

Free Cash Flow

-$1.95M

+1.2%

Operating Cash Flow

-$1.95M

+1.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ELABPMGC Holdings Inc.

ELABPMGC Holdings Inc.$1.45-1.36%

INMInMed Pharmaceuticals Inc.

INMInMed Pharmaceuticals Inc.$1.54+1.99%

MLECMoolec Science S.A.

MLECMoolec Science S.A.$7.65+5.44%

BDRXBiodexa Pharmaceuticals Plc

BDRXBiodexa Pharmaceuticals Plc$3.15+3.96%

VRAXVirax Biolabs Group Limited

VRAXVirax Biolabs Group Limited$0.19+0.60%

ISPCiSpecimen Inc.

ISPCiSpecimen Inc.$2.82+2.55%

NKGNNKGen Biotech, Inc. Common Stock

NKGNNKGen Biotech, Inc. Common Stock$0.06+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

ONDSOndas

ONDSOndas$9.33-0.05%

SOFISoFi Technologies

SOFISoFi Technologies$16.58-0.01%

ASTSAST SpaceMobile

ASTSAST SpaceMobile$82.41-0.16%

Questions About GLMD

What is the current price of Galmed Pharmaceuticals?

Galmed Pharmaceuticals is trading at $0.61 per share.

What is the 52-week range for Galmed Pharmaceuticals?

Over the past 52 weeks, Galmed Pharmaceuticals has traded between $0.41 and $2.34.

How much debt does Galmed Pharmaceuticals have?

As of the most recent reporting period, Galmed Pharmaceuticals reported total debt of $0.00.

How much cash does Galmed Pharmaceuticals have on hand?

Galmed Pharmaceuticals reported $4.11M in cash and cash equivalents in its most recent financial results.

What is Galmed Pharmaceuticals’s dividend yield?

Galmed Pharmaceuticals does not currently have a dividend yield.

Galmed Pharmaceuticals

Galmed Pharmaceuticals Financials at a Glance

GLMD News

These Small Cap Biopharma Stocks Lost as Much as 34.1% in October. Are They Buys?

Here's Why Galmed Pharmaceuticals Ltd. Was Up 19% Today and 33% for the Week

3 NASH Stocks That Could Soar in the Second Half of 2018

Are These Red-Hot NASH Stocks Still a Buy?

Why Galmed Pharmaceuticals Ltd. Stock Is Skyrocketing Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Galmed Pharmaceuticals

GLMD Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Galmed Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GLMD

What is the current price of Galmed Pharmaceuticals?

What is the 52-week range for Galmed Pharmaceuticals?

How much debt does Galmed Pharmaceuticals have?

How much cash does Galmed Pharmaceuticals have on hand?

What is Galmed Pharmaceuticals’s dividend yield?

Premium Investing Services